World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
45186
World Ranking
7870
National Ranking
446

David Capper publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David Capper sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 574 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David Capper D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David Capper sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David Capper is affiliated with Charité - University Medicine Berlin in Germany. Their research spans extensive work in the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a specific focus on Genetics, Molecular Biology, Cancer Research, Neurology, and Pulmonary and Respiratory Medicine.

The primary research topics addressed by David Capper include:

  • Glioma Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Epigenetics and DNA Methylation
  • Cancer Genomics and Diagnostics
  • Brain Metastases and Treatment
  • Neuroblastoma Research and Treatments
  • Cancer-related molecular mechanisms research

They have contributed to numerous publications across various scientific venues. Frequent publication platforms for their work include:

  • Neuro-Oncology
  • Acta Neuropathologica
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Neuro-Oncology
  • Neuro-Oncology Advances

David Capper has collaborated extensively with several co-authors, including Felix Sahm, Andreas von Deimling, Stefan M. Pfister, David Jones, and Ulrich Schüller.

Selected recent publications highlighting themes within their research are:

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading, 2020, Brain Pathology
  • Primary brain tumours in adults, 2023, The Lancet
  • cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors, 2020, Brain Pathology
  • The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets, 2021, Cancer Discovery
  • Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data, 2020, Nature Protocols

Best Publications

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • A complex secretory program orchestrated by the inflammasome controls paracrine senescence

    Juan Carlos Acosta;Ana Banito;Torsten Wuestefeld;Athena Georgilis

  • Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

    Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik

  • Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

    Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper

  • Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

    Kristian W. Pajtler;Kristian W. Pajtler;Hendrik Witt;Martin Sill;David T.W. Jones

  • Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas

    Christian Hartmann;Christian Hartmann;Bettina Hentschel;Wolfgang Wick;Wolfgang Wick;David Capper

  • The whole-genome landscape of medulloblastoma subtypes

    Paul A. Northcott;Paul A. Northcott;Ivo Buchhalter;Ivo Buchhalter;A. Sorana Morrissy;Volker Hovestadt

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • WHO 2016 Classification of gliomas

    Pieter Wesseling;Pieter Wesseling;David Capper;David Capper;David Capper

  • DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

    Felix Sahm;Felix Sahm;Daniel Schrimpf;Damian Stichel;David T.W. Jones

  • Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.

    David Capper;Susanne Weißert;Jörg Balss;Antje Habel

  • ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.

    David E. Reuss;Felix Sahm;Felix Sahm;Daniel Schrimpf;Daniel Schrimpf;Benedikt Wiestler;Benedikt Wiestler

  • Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

    David Capper;David Capper;Matthias Preusser;Matthias Preusser;Antje Habel;Felix Sahm;Felix Sahm

  • Monoclonal antibody specific for IDH1 R132H mutation.

    David Capper;Hanswalter Zentgraf;Jörg Balss;Christian Hartmann;Christian Hartmann

  • Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

    Pascal D. Johann;Pascal D. Johann;Serap Erkek;Marc Zapatka;Kornelius Kerl

  • Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

    Brigitta G Baumert;Brigitta G Baumert;Monika E Hegi;Martin J van den Bent;Andreas von Deimling

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.

    David N. Louis;Pieter Wesseling;Kenneth Aldape;Daniel J. Brat

  • Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

    David Capper;Damian Stichel;Damian Stichel;Felix Sahm;Felix Sahm;David T. W. Jones

  • ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

    Benedikt Wiestler;David Capper;David Capper;Tim Holland-Letz;Andrey Korshunov;Andrey Korshunov

Frequent Co-Authors

Andreas von Deimling
Andreas von Deimling Heidelberg University
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Felix Sahm
Felix Sahm University Hospital Heidelberg
David T. W. Jones
David T. W. Jones German Cancer Research Center
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Christian Hartmann
Christian Hartmann Hannover Medical School
Christel Herold-Mende
Christel Herold-Mende Heidelberg University
Marcel Kool
Marcel Kool German Cancer Research Center
Michael Weller
Michael Weller University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can open up diverse career options beyond traditional medical school. For registered nurses aiming to advance, rn to fnp bridge programs provide a streamlined route to becoming a Family Nurse Practitioner, blending flexibility with career progression.

If you're interested in nutrition and preventative medicine, enrolling in an online bachelor's degree in nutrition delivers foundational knowledge for careers in wellness, healthcare education, and food science—often from the convenience of home.

For healthcare management roles, ensure your degree has credibility and value. Programs like which online healthcare degree programs are recognized for their accreditation by cahme? safeguard your investment in education by meeting strict professional standards.

Some working nurses prefer minimal in-person requirements. Options such as online rn-bsn programs without clinicals allow for academic progression without on-site practicums, supporting busy professionals in achieving their academic goals.

These online pathways can complement or even replace traditional routes, offering flexibility, accreditation, and specialized knowledge suited to today's evolving healthcare landscape.

Best Scientists Citing David Capper

Trending Scientists

Recently Published Articles